ArticleActa pharmaceutica Sinica. B2022

Light-controllable charge-reversal nanoparticles with polyinosinic-polycytidylic acid for enhancing immunotherapy of triple negative breast cancer.

Lei Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.